BNP Paribas Bonus Zert MS 26.06.2.../ DE000PC5MK48 /
25/06/2024 09:22:42 | Var.+0.29 | Denaro13:59:31 | Lettera13:59:31 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
79.15EUR | +0.37% | 79.28 Quantità in denaro: 2,000 |
79.68 Quantità in lettera: 2,000 |
Morgan Stanley | - USD | 26/06/2025 | Call |
GlobeNewswire
14:15
Ingersoll Rand Names Scott Watson as Leader for Life Science Technologies Platform
GlobeNewswire
14:15
Prima at Paseo South Gulch Introduces Electric Car Sharing Program for Residents through Envoy Techn...
GlobeNewswire
14:07
Industry Leader John Maraganore, Ph.D., Joins Cybrexa Therapeutics as Strategic Advisor
GlobeNewswire
14:05
N2OFFAnnounces Breakthrough in Reducing N₂O Emissions with Innovative Bacterial Technology in Corn C...
GlobeNewswire
14:05
Tevogen Bio Announces Publication of Positive Phase I Clinical Trial Results for TVGN 489 in Blood A...
GlobeNewswire
14:00
Data Supporting Nanox.AI Cardiac Solution to Be Presented at 19th Annual Meeting of the Society of C...
GlobeNewswire
14:00
Lightbridge Welcomes Passage of the ADVANCE Act, Landmark Legislation to Expedite Commercial Deploym...
GlobeNewswire
14:00
AFCEA International Proudly Announces New Board Chair, Vice Chair, Executive Committee and Board of ...
GlobeNewswire
14:00
Stingray Delivers Popular Music and Concert Content to The Roku Channel in the US and Canada
Newsfile Corp
14:00
Teako Minerals Successfully Concludes Sandefjord Rare Earth Element Program and Mobilizes Field Crew...
GlobeNewswire
14:00
LOBO EV Strengthens Partnership with a Well-Established Brazilian Distributor Following Successful O...
GlobeNewswire
14:00
Aquestive Therapeutics Reports Positive Topline Data from Temperature / pH Study of Anaphylm™ (epine...
GlobeNewswire
14:00
Treasure Global Inc Announces New Leadership Team to Drive New Vision and Strategy Forward
GlobeNewswire
14:00
BioVie Presents Protocol Design of Upcoming SUNRISE-PD Phase 2 Trial of Bezisterim in Patients with ...
GlobeNewswire
14:00
Recce Pharmaceuticals Receives Ethics Approval to Broaden RECCE® 327 Gel Trials Across all Topical B...